In the past four months, Indus Towers has outperformed the market by soaring 31%, as compared to 3.7% rise in the BSE Sensex.
Over the next three years, analysts expect the company's EPS to grow at a CAGR of 23 per cent, from ₹104 to ₹195
B&K Securities expects Travel Food Services to benefit from India's expanding airport network, with new terminals and capacity additions likely to drive steady passenger growth at 1.5-2x GDP
LG Electronics share price declined after around 15 million shares of the company's outstanding equity, became eligible for trading following the expiry of the lock-in
US tariff impact? In the past seven weeks, the market price of Gokaldas Exports has plunged 33 per cent from a level of ₹948.85 on November 20, 2025 on the BSE.
Gland Pharma jumped 4.80 per cent to ₹1,790.40, the highest level since December 3, 2025, on the National Stock Exchange.
The growth, they said, will be driven by higher cost per vehicle (CPV) amid upcoming emission norms, a shift towards premium offerings, deeper market penetration, and a rising contribution from export
Real-estate stocks in focus: However, in the past six months, Nifty Realty index has underperformed the market by falling 7.4 per cent, as against 2.1 per cent rise in the Nifty 50.
APL Apollo reported sales volumes of 916,976 tonnes in the quarter, up from 855,037 tonnes in Q2FY26 and 828,200 tonnes in the year-ago period
With improving execution discipline, stronger order inflows, and an international scale-up, analysts believe the company is well-placed for a profitability-led growth trajectory
Choice noted Aurionpro Solutions is undergoing a strategic shift under CEO Ashish Rai, moving from a hybrid IT services-product model to a product-first
The brokerage highlighted the strength of CFSL's blend portfolio and its Vinpai acquisition, both of which are expected to drive strong margins, create entry barriers, &unlock solid revenue potential
BHEL stock is well placed to gain from the need for building base load thermal coupled with strong revenue visibility in the medium term, believe analysts.
In the past two trading days, the Nifty Pharma index has rallied 3.3 per cent, as compared to 0.41 per cent decline in the Nifty 50.
Meesho is currently trading at 7.4 per cent above its listing price on BSE of ₹161.2 per share and 56 per cent above its issue price of ₹111 per share.
The stock price of Kaynes Technology hit a 52-week low of ₹3,682.15 in intra-day trade on Wednesday, and has corrected 52 per cent from its 52-week high of ₹7,705 touched on October 7, 2025.
Antique upgraded Jubilant FoodWorks to a buy from its earlier rating, and raised the target price to ₹620 from ₹600, citing favourable valuations and sustained outperformance
Antique assigned a target price of ₹750 per share for Studds Accessories, implying an upside of about 40 per cent from the current market price
Titan's jewellery portfolio clocked a 41 per cent Y-o-Y growth in Q3FY26, driven by substantial average selling price (ASP) increases, offsetting flattish buyer growths.
Lodha Developers, Nomura said, has maintained its FY26E presales guidance of ₹21,000 crore, implying a Q4FY26F presales target of ₹6,500 crore (up 35 per cent Y-o-Y)